A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 113
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VP1
Long Form : viral protein 1
No. Year Title Co-occurring Abbreviation
2019 Deciphering foot-and-mouth disease (FMD) virus-host tropism. FMD, RGD
2019 Hepatitis A Virus Capsid Structure. Fab, HAV
2019 Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines. AFP, EV-A71, HFMD, NPEVs
2019 Ubiquitination Is Essential for Avibirnavirus Replication by Supporting VP1 Polymerase Activity. IBDV
2019 Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. EV71, SCARB2
2018 Different Strains of BK Polyomavirus: VP1 Sequences in a Group of Iranian Prostate Cancer Patients. BKV
2018 ERK Is a Critical Regulator of JC Polyomavirus Infection. 5-HT2Rs, ERK, JCPyV, LSTc, MAPK, PML, siRNA, SV40, Tag
2018 High frequency of Polio-like Enterovirus C strains with differential clustering of CVA-13 and EV-C99 subgenotypes in a cohort of Malawian children. EV-A, EVs, PV
2018 Identification and genetic characterization of polyomaviruses in estrildid and fringillid finches. ---
10  2018 Identification of recombinant coxsackievirus A6 variants in hand, foot and mouth disease in Nanjing, China, 2013. CVA, EV, HFMD, NS, RFs
11  2018 Isolation, molecular characterization and sero-prevalence study of foot-and-mouth disease virus circulating in central Ethiopia. CPE, FMD, FMDV
12  2018 Lack of Transmission of Foot-and-Mouth Disease Virus From Persistently Infected Cattle to Naive Cattle Under Field Conditions in Vietnam. FMD, FMDV, OPF
13  2018 MicroR-9-5p suppresses EV71 replication through targeting NFkappaB of the RIG-I-mediated innate immune response. EV71, IRF3, miR-9, NF-kappaB
14  2018 Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan, China. CA16, EV71, EVs, HFMD
15  2018 Molecular epidemiology of coxsackievirus A6 derived from hand, foot, and mouth disease in Fukuoka between 2013 and 2017. CV, HFMD
16  2018 Molecular Epidemiology of Foot-and-Mouth Disease Virus in the Context of Transboundary Animal Movement in the Far North Region of Cameroon. FMDV, OPF
17  2018 Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system. rAAV
18  2017 Characterization of group B coxsackieviruses isolated from non-polio acute flaccid paralysis patients in Pakistan: vital assessment before polio eradication. AFP, CV, CVB, NPEVs
19  2017 CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus. JCPyV, PML
20  2017 Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan. ARIs, EV-D68
21  2017 Eukaryotic translational initiation factor 4AII reduces the replication of infectious bursal disease virus by inhibiting VP1 polymerase activity. eIF4AII, IBD, IBDV, RdRp
22  2017 High-Throughput Next-Generation Sequencing of Polioviruses. NGS, PV, RT, VDPV
23  2017 Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan. CV, EV, HFMD
24  2017 JC virus infection is acquired very early in life: evidence from a longitudinal serological study. ELISA, JCV, nOD
25  2017 Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines. IPV, OPV
26  2017 Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belem, Brazil: A community-based longitudinal study. NoV
27  2017 Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belem, Brazil: A community-based longitudinal study. NoV
28  2017 Multiplex detection in tonsillar tissue of all known human polyomaviruses. HPyVs
29  2017 [Human EV71 invades human neuroblastoma SK-N-SH cells by clathrin-mediated endocytosis]. CPZ, EV71, NT
30  2016 A transgenic plant cell-suspension system for expression of epitopes on chimeric Bamboo mosaic virus particles. BaMV, CVPs, FMDV
31  2016 Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. IPV, OPV
32  2016 Detection of enterovirus D68 in patients hospitalised in three tertiary university hospitals in Germany, 2013 to 2014. EV-D68
33  2016 Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation. 5'-TOP
34  2016 Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. AFP, EV, EV-D68, US
35  2016 Genomic Surveillance Elucidates Persistent Wild Poliovirus Transmission During 2013-2015 in Major Reservoir Areas of Pakistan. WPV1
36  2016 GenSeed-HMM: A Tool for Progressive Assembly Using Profile HMMs as Seeds and its Application in Alpavirinae Viral Discovery from Metagenomic Data. HMM, MSA
37  2016 Human IgG Fc promotes expression, secretion and immunogenicity of enterovirus 71 VP1 protein. hFc
38  2016 Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF alpha: A 18 Month Follow-Up Study. CIRDs, JC, NCCR, PML
39  2016 Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013. NS1, PCR
40  2016 Phylogenetic and structural analysis of merkel cell polyomavirus VP1 in Brazilian samples. BCC, MCPyV
41  2016 Respiratory infections associated with enterovirus D68 from 2011 to 2015 in Beijing, China. EV-D68
42  2016 Serological and molecular investigation of porcine sapovirus infection in piglets in Xinjiang, China. PoSaV
43  2016 Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells. JCPyV, PML
44  2016 Survey of molecular chaperone requirement for the biosynthesis of hamster polyomavirus VP1 protein in Saccharomyces cerevisiae. EGFP, HSP70, VLPs
45  2015 A computational study of the interaction of the foot and mouth disease virus VP1 with monoclonal antibodies. FMDV
46  2015 Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy. CSF, HDs, IRIS, JCPyV, NAT, PML
47  2015 Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy. HM, HRVs, LRTI, URTI
48  2015 Development of Novel Vaccines against Enterovirus-71. VLPs
49  2015 Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin. HAV, HEV, ODNs, ORF2
50  2015 Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes. TSPyV, VLPs
51  2015 Foot-and-mouth disease virus serotype SAT 3 in long-horned Ankole calf, Uganda. ---
52  2015 High Frequency of JCV DNA Detection in Prostate Cancer Tissues. NCCR, PC
53  2015 Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins. JCPyV, PML
54  2015 Optimisation and analysis of polymerase chain reaction based DNA sequencing for genotyping polyoma virus in renal transplant patients: a report from South India. BKV, JCV, PCR
55  2015 Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. GII.4
56  2015 Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1. PML
57  2015 Trypsin diminishes the rat potency of polio serotype 3. EP
58  2014 Novel Drosophila viruses encode host-specific suppressors of RNAi. Ago2, DmelNV
59  2014 Phylogenetic analysis of Merkel cell polyomavirus based on full-length LT and VP1 gene sequences derived from neoplastic tumours in Japanese patients. LT, MCPyV
60  2014 Phylogenetic analysis of the VP1 gene of Enterovirus 71 in Guangzhou during the high occurrence period of 2008. EV71, HFMD
61  2013 Detection of Aichi virus with antibody targeting of conserved viral protein 1 epitope. AiV
62  2013 Genetic characterization of Duck Hepatitis A Viruses isolated in China. DHAVs
63  2013 Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. CD, JC, MS, NCCR, PBMCs, PML
64  2013 Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2. HCMV, JCV, TCR
65  2013 Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy. HIV, MS, PML, TCR
66  2013 Molecular evolution of enterovirus 68 detected in the Philippines. 5'UTR, EV68, PCR
67  2013 The structure and host entry of an invertebrate parvovirus. AdDNV
68  2013 [Sequence analysis of VP1 gene of the duck hepatitis A virus type 3 strains isolated from Shandong Province of China in 2012]. DHAV-3, GI, GII
69  2012 Association between the JC polyomavirus infection and male infertility. ---
70  2012 Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains. GII.4, NoV
71  2012 Detection of BK virus in urine from renal transplant subjects by mass spectrometry. AR, BKV, BKVAN, MS
72  2012 Detection of Merkel cell polyomavirus in cervical squamous cell carcinomas and adenocarcinomas from Japanese patients. ACs, HPV, LT, MCC, MCPyV, PCR, SCCs
73  2012 Genetic variation of the VP1 gene of the virulent duck hepatitis A virus type 1 (DHAV-1) isolates in Shandong province of China. DHAV-1
74  2012 Structural basis for the recognition of Lewis antigens by genogroup I norovirus. alpha4Fuc, NoVs
75  2011 Molecular diagnosis and clinical presentations of enteroviral infections in Taipei during the 2008 epidemic. CA2, EV, HFMD, RT-PCR
76  2011 Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma. BCC, LT3, MCC, MCPyV, PCR, SCC
77  2011 Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. JCV, PML, VLPs
78  2011 Structures of the major capsid proteins of the human Karolinska Institutet and Washington University polyomaviruses. ---
79  2011 [Etiology survey on an outbreak of viral encephalitis]. EV
80  2010 Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary. 5'-UTR, mOPV, VAPP
81  2009 Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. HRV
82  2008 Detecting small changes and additional peptides in the canine parvovirus capsid structure. ---
83  2008 Detection of hepatitis A virus RNA from children patients with acute and fulminant hepatitis of unknown etiology in Vietnam: Genomic characterization of Vietnamese HAV strain. HAV
84  2008 Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. CEA, scFv
85  2008 Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. IPV, ITD, OPV
86  2007 Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. EV, MI, RNA
87  2007 Cloning and expression of coxsakievirus B3 viral protein-1 in E. coli. CVB3
88  2007 Evidence for functional significance of the permuted C motif in Co2+-stimulated RNA-dependent RNA polymerase of infectious bursal disease virus. IBDV, RdRp
89  2007 Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. BKV
90  2007 The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. ---
91  2006 PARP-1 interaction with VP1 capsid protein regulates polyomavirus early gene expression. PARP-1
92  2006 Spliced mRNAs detected during the life cycle of Chicken anemia virus. CAV, p.i, TTV
93  2004 Genetic variation of viral protein 1 genes of field strains of waterfowl parvoviruses and their attenuated derivatives. GPV, MDPV
94  2004 Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules. ---
95  2004 VP1, the RNA-dependent RNA polymerase and genome-linked protein of infectious bursal disease virus, interacts with the carboxy-terminal domain of translational eukaryotic initiation factor 4AII. eIF4AII, IBDV
96  2003 A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid. HRVs, VLDL-R
97  2003 Chaperone-mediated in vitro assembly of Polyomavirus capsids. ---
98  2002 Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1). AAA, EB, ELISA, RT
99  2001 Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding. ERAV, FMDV, GST
100  2001 Immune response in progressive multifocal leukoencephalopathy: an overview. CNS, CSF, PBMC, PML